Bacteriophage Therapy: Alternatives to Antibiotics

  • Thread starter Thread starter micromass
  • Start date Start date
  • Tags Tags
    Therapy
Click For Summary

Discussion Overview

The discussion revolves around bacteriophage therapy as a potential alternative to antibiotics, exploring its viability, regulatory challenges, and the broader implications of antibiotic resistance. Participants examine the current state of bacteriophage therapy, its application in different regions, and the obstacles faced in clinical adoption.

Discussion Character

  • Exploratory
  • Debate/contested
  • Technical explanation
  • Conceptual clarification

Main Points Raised

  • Some participants express concern that antibiotics may soon become ineffective and suggest bacteriophage therapy as a viable alternative.
  • Others question the assertion that the government does not allow bacteriophage therapy, citing specific laws in states like Washington and Texas that permit its experimental use.
  • It is noted that the FDA requires therapies to be proven safe and effective through clinical trials, and no bacteriophage therapy has yet met this standard.
  • Participants highlight the species-specific nature of bacteriophages compared to the broader spectrum of antibiotics, suggesting that rapid diagnostic advancements are necessary for practical application of phage therapy.
  • Concerns are raised about the lack of funding and incentives for pharmaceutical companies to develop specific phage therapies, as well as the low cost of existing antibiotics setting a low bar for treatment costs.
  • Some participants discuss the communication barriers in healthcare that may affect the diagnosis and treatment of infections, which could complicate the implementation of phage therapy.
  • It is mentioned that phage therapy is still utilized in Russia and other former Soviet nations, with references to articles discussing its limitations and potential.
  • Participants note the ethical considerations surrounding the pursuit of phage therapy, especially in light of rising antibiotic resistance and untreatable infections.
  • Some express skepticism about the safety of phage therapy, raising concerns about potential cytotoxicity and immunogenicity.
  • One participant discusses the challenges of using live viruses in treatment and the immune response they may provoke, suggesting that genetic technology might offer solutions in the future.

Areas of Agreement / Disagreement

Participants do not reach a consensus on the regulatory status of bacteriophage therapy, the challenges it faces, or its overall safety and efficacy. Multiple competing views and uncertainties remain throughout the discussion.

Contextual Notes

Limitations include the dependence on regulatory definitions, the unclear status of clinical trials for phage therapy, and the unresolved challenges related to immune responses to bacteriophages.

micromass
Staff Emeritus
Science Advisor
Homework Helper
Insights Author
Messages
22,170
Reaction score
3,327
Antibiotics have come a long way since their discovery. But I think it will happen quite soon that they'll be ineffective. So what are the alternatives? I've read a bit about bacteriophage therapies which could possibly form an effective alternative to antibiotics. On the other hand, the government currently do not allow any bacteriophage therapy on humans. So why is this? Why isn't this alternative taken seriously?
 
Biology news on Phys.org
micromass said:
On the other hand, the government currently do not allow any bacteriophage therapy on humans

What government?

https://en.wikipedia.org/wiki/Phage_therapy

"Washington and Oregon law allows naturopathic physicians to use any therapy that is legal any place in the world on an experimental basis.[49]

In Texas phages are considered natural substances and can be used in addition to (but not as a replacement for) traditional therapy; they've been used routinely in a wound care clinic in Lubbock, TX, since 2006.[50]"
 
micromass said:
On the other hand, the government currently do not allow any bacteriophage therapy on humans. So why is this? Why isn't this alternative taken seriously?

The FDA approves therapies for clinical use only after therapies have been proven safe and effective in clinical trials. No bacteriophage therapy has passed this bar yet.

One challenge with bacteriophage therapy is that bacteriophages are very species specific whereas antibiotics typically act on a more broad spectrum of bacteria. Bacteriophage therapy may require advances in rapid diagnosis to identify the exact bacteria involved before phage therapy becomes practical.
 
  • Like
Likes   Reactions: Laroxe
The largest challenge here is that the pharmaceutical and biotechnology industries need a big incentive (funding, of course) for developing and testing so many specific phage therapies/alternatives than can realistically be supported. Also, antibiotics are cheap and have set the bar low for treatment costs, that is a large-scale change for many different entities involved. I think the alternative isn't being taken so seriously because humans wait until it's a full-blow crisis before doing anything.

As far as diagnosis, in my area, I've sensed a large communication barrier in the healthcare field and research. Many diagnoses are now being left to nurse practitioners and nurses are making more decisions than ever before, my fear is that they aren't exactly obligated to remain so relevant or may not even have the initial training... Very young children are constantly being prescribed antibiotics for common infections that are not supported by clinical trials to be beneficial. I have had at least 2 ER nurses 'diagnose' my daughter with a middle ear infection before checking her! We can assume if there are so many issues in making a diagnosis at those levels already, where many infections are diagnosed with symptoms, not lab reports, and not always by doctors, then there will be as many in using phage therapy. That could be a good thing though, it would force the diagnosis to be proved first?
 
Ygggdrasil said:
The FDA approves therapies for clinical use only after therapies have been proven safe and effective in clinical trials. No bacteriophage therapy has passed this bar yet.

One challenge with bacteriophage therapy is that bacteriophages are very species specific whereas antibiotics typically act on a more broad spectrum of bacteria. Bacteriophage therapy may require advances in rapid diagnosis to identify the exact bacteria involved before phage therapy becomes practical.

o_O What is going on here? Did you have the letter y in your username capitalized? I swear it was a lower-case y not long ago! Please tell me, it's driving me bonkers looking at it! I need to know. I do like it much better this way though.
 
Fervent Freyja said:
What is going on here? Did you have the letter y in your username capitalized? I swear it was a lower-case y not long ago! Please tell me, it's driving me bonkers looking at it! I need to know. I do like it much better this way though.
I haven't changed anything recently, and as far as I know, it's always been capitalized. Maybe the font somehow changed?
 
Ygggdrasil said:
I haven't changed anything recently, and as far as I know, it's always been capitalized. Maybe the font somehow changed?

Huh, then I really did write it incorrectly in a prior post. It's one thing to know when you are wrong and let the mistake slide, but another when you don't realize it until way later, if ever. Thanks. :smile:
 
Funny name. :angel:
 
It's worth noting that phage therapy is still used in Russia and other former Soviet Union nations:
http://www.nature.com/news/phage-therapy-gets-revitalized-1.15348

I started typing out a longer answer but in the course of looking up a few facts found this article which seems pretty comprehensive on the matter:

What are the limitations on the wider use of phage therapy?
Alexandra Henein, 2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821673/

Abstract said:
Bacterial resistance to antibiotics poses a serious health threat. Since research into new antibiotics is not progressing at the same rate as the development of bacterial resistance, widespread calls for alternatives to antibiotics have been made. Phage therapy is an ideal alternative candidate to be investigated. However the success of phage therapy may be hampered by a lack of investment support from large pharmaceutical companies, due to their narrow spectrum of activity in antibiotics, very large costs associated with clinical trials of the variety of phages needed, and regulatory requirements remaining unclear. Intellectual property is difficult to secure for therapeutic phage products for a variety of reasons, and patenting procedures vary widely between the US and the EU. Consequently, companies are more likely to invest in phage products for decontamination or veterinary use, rather than clinical use in humans. Some still raise questions as to the safety of phage therapy overall, suggesting the possibility of cytotoxicity and immunogenicity, depending on the phage preparation and route. On the other hand, with patients dying because of infections untreatable with conventional antibiotics, the question arises as to whether it is ethical not to pursue phage therapy more diligently. A paradigm shift about how phage therapy is perceived is required, as well as more rigorous proof of efficacy in the form of clinical trials of existing medicinal phage products. Phage therapy potential may be fulfilled in the meantime by allowing individual preparations to be used on a named-patient basis, with extensive monitoring and multidisciplinary team input. The National Health Service and academia have a role in carrying out clinical phage research, which would be beneficial to public health, but not necessarily financially rewarding.
 
  • #10
Its not that "Big Pharm" whoever that is, is disinterested, there has been quite a lot of work done on using phages and indeed Russian has the largest collection of phages on the planet. The problem is that bacteriophages are viruses that attack bacteria, treatment would involve injecting large doses of these live viruses into the body to destroy the invading organisms, so far no one has worked out a way of telling our own immune system that these phages are on our side, they see this as a further challenge and react accordingly. Even using phages to treat local wounds can only be done for a short period before causing a reaction.
I've read somewhere that it might be possible to use some of the new genetic technology to get around this, but nothing recently.
Antibiotic resistance is interesting in that its not just about antibiotic use, bugs are capable of sharing resistance by exchanging genetic code, with good antibiotic control, particularly if some can be taken off the market, these pieces of code will have no function and will probably be exchanged for something more useful. There is also the possibility because many antibiotics are natural products, the organisms that produce them may be pushed into making changes themselves, this is the very essence of natural selection. Though I don't suppose we should hold our breath.
 
  • Like
Likes   Reactions: Ygggdrasil

Similar threads

  • · Replies 18 ·
Replies
18
Views
6K
  • · Replies 14 ·
Replies
14
Views
6K
Replies
15
Views
5K
  • · Replies 5 ·
Replies
5
Views
3K
  • · Replies 4 ·
Replies
4
Views
3K
  • · Replies 3 ·
Replies
3
Views
6K
  • · Replies 17 ·
Replies
17
Views
5K
Replies
3
Views
19K
  • · Replies 16 ·
Replies
16
Views
3K
Replies
5
Views
3K